4-氨基-[2,3']联噻吩-5-甲酰胺
![4-氨基-[2,3']联噻吩-5-甲酰胺结构式](https://image.chemsrc.com/caspic/085/354812-17-2.png)
4-氨基-[2,3']联噻吩-5-甲酰胺结构式
|
常用名 | 4-氨基-[2,3']联噻吩-5-甲酰胺 | 英文名 | SC-514 |
|---|---|---|---|---|
| CAS号 | 354812-17-2 | 分子量 | 224.303 | |
| 密度 | 1.5±0.1 g/cm3 | 沸点 | 399.2±42.0 °C at 760 mmHg | |
| 分子式 | C9H8N2OS2 | 熔点 | 209-211°C | |
| MSDS | 中文版 美版 | 闪点 | 195.2±27.9 °C | |
| 符号 |
GHS06 |
信号词 | Danger |
|
Methylprednisolone attenuates lipopolysaccharide-induced Fractalkine expression in kidney of Lupus-prone MRL/lpr mice through the NF-kappaB pathway.
BMC Nephrol. 16 , 148, (2015) Fractalkine (FKN) is involved in the occurrence and development of human lupus nephritis. It is known to be upregulated by lipopolysaccharide (LPS) as a stimulus in vivo. MRL/lpr mice have been used as an in vivo model to study lupus nephritis. Methylpredniso... |
期刊文献综述：
更多...